Nobalanda Betty Mokoena

Title: Nobalanda Betty Mokoena: Innovator in Vaccine Development

Introduction

Nobalanda Betty Mokoena is a notable inventor based in Montana, South Africa. She has made significant contributions to the field of vaccine development, particularly in the area of synthetic vaccines. With a total of 2 patents, her work is paving the way for advancements in medical science.

Latest Patents

Mokoena's latest patents focus on plant-produced chimaeric orbivirus virus-like particles (VLPs). This invention relates to a second-generation, plant-produced synthetic Orbivirus candidate vaccine. The vaccine comprises a plant-produced chimaeric Orbivirus VLP that includes at least one structural protein from one Orbivirus serotype and at least one structural protein from another serotype of the Orbivirus. Both structural capsid proteins are derived from the same Orbivirus species. This invention aims to provide a method for preventing and treating Orbivirus infections, showcasing her innovative approach to vaccine development.

Career Highlights

Throughout her career, Mokoena has worked with esteemed organizations such as the Council for Scientific and Industrial Research (CSIR) and the University of Cape Town. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Mokoena has collaborated with notable colleagues, including Albertha René Van Zyl and Ann Elizabeth Meyers. These partnerships have further enriched her research and development efforts in the realm of vaccine innovation.

Conclusion

Nobalanda Betty Mokoena is a pioneering inventor whose work in vaccine development is making a significant impact in the fight against infectious diseases. Her innovative patents and collaborations highlight her dedication to advancing medical science.